Microbot Medical shares are trading higher after the company announced it achieved a 100% success rate for the LIBERTY system in an extensive pre-clinical animal study performed by leading European physicians.
Portfolio Pulse from Benzinga Newsdesk
Microbot Medical announced a 100% success rate for its LIBERTY system in a pre-clinical animal study conducted by leading European physicians, causing its shares to trade higher.
May 22, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Microbot Medical's shares are trading higher after achieving a 100% success rate for the LIBERTY system in a pre-clinical animal study.
The 100% success rate in the pre-clinical animal study indicates that the LIBERTY system is effective and has potential for future growth. This positive news is likely to boost investor confidence in Microbot Medical, leading to an increase in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100